Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Orange at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This is a global, multi-center, Phase 3 study that is randomized 2:1, controlled, and open label to evaluate PDS0101 (Versamune + HPVMix) in combination with pembrolizumab vs. pembrolizumab monotherapy as first-line treatment in patients with unresectable recurrent or metastatic HPV16-positive HNSCC expressing programmed cell death ligand-1 (PD-L1) with combined positive score (CPS) ≥1.
Sponsor: PDS Biotechnology Corp.
Check if you qualify for this head and neck cancer clinical trial in Orange, CA
If you're searching for head and neck cancer treatment options in Orange, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.